Treatment with BIIB122/DNL151 achieved robust reductions in biomarkers of target engagement and pathway engagement in healthy volunteers and patients with...
Preclinical data support novel approaches for the treatment of Usher Syndrome 2A and retinitis pigmentosa 4CAMBRIDGE, Mass., May 01, 2021...
Analytical assessment demonstrates structural, physicochemical, and biological similarity between SB11 and Lucentis SB11 is under review by the FDA and...
In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual...
CHICAGO, April 30, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 30, 2021 (GLOBE NEWSWIRE)...
PARIS, FRANCE / ACCESSWIRE / April 30, 2021 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company developing...
DALLAS, TX / ACCESSWIRE / April 30, 2021 / Millennium Family Practice, in Columbia, Maryland, provides quality medical care for people...
ImmunopheresisTM is shown to be well-tolerated in treating cancer patients who failed multiple lines of standard therapies SAN DIEGO--(BUSINESS WIRE)--#biotech--Immunicom,...
WATERLOO, ON / ACCESSWIRE / April 30, 2021 / Cloud DX (TSXV:CDX) (The Company) a leading Canadian provider of virtual...
A Presentation of Positive Preliminary Efficacy Results from the FOCUS Phase III trial Company Q&A Webinar Scheduled for Monday, June 7,...
PRAX-562 Phase 2 clinical trial for treatment of DEEs expected to initiate in first half of 2022CAMBRIDGE, Mass., April 30,...
REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced...
A single-day dose of oral ibrexafungerp demonstrates positive clinical outcomes in difficult-to-treat vulvovaginal candidiasis (VVC) patient populations: those with non-albicans...
The partnership builds on Sientra’s safety profile by empowering surgeons with Butterfly Network’s cutting-edge point-of-care ultrasound technology to screen and...
SAN FRANCISCO and SAN DIEGO, April 30, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company...
Conference Call and Webcast Scheduled for May 6, 2021, 4:30 p.m. Eastern TimePRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) --...
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company...
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, general manager, eric.nys@financiere-tubize.be Approval...